A scientist works at Zai Lab's drug development facility in Shanghai on October 18, 2017. Photo: REUTERSA scientist works at Zai Lab's drug development facility in Shanghai on October 18, 2017. Photo: REUTERS
A scientist works at Zai Lab's drug development facility in Shanghai on October 18, 2017. Photo: REUTERS

Baozun, Zai Lab join march of New York-listed companies to raise more capital in Hong Kong as US-China ties deteriorate

  • E-commerce Baozun, biotech firm Zai Lab launch Hong Kong public offerings as more US-listed firms seek listings closer to home
  • A spate of secondary listings help end this week as one of the busiest in fundraising, as ZTO Express has also launched US$1.6 billion deal

Topic |   IPO
A scientist works at Zai Lab's drug development facility in Shanghai on October 18, 2017. Photo: REUTERSA scientist works at Zai Lab's drug development facility in Shanghai on October 18, 2017. Photo: REUTERS
A scientist works at Zai Lab's drug development facility in Shanghai on October 18, 2017. Photo: REUTERS
READ FULL ARTICLE
Close
We need your support

Advertising helps us continue to provide quality content. Help support us by disabling your adblocker on our site.

How to whitelist us:
  1. 1
    Click on the AdBlock icon at the top right corner of your browser.
    For iOS, go to Settings/Safari/Content Blockers and turn it off.

    For Android, go to your Ad blocker app/Settings and turn it off.
  2. 2
    Click Enabled on this site until the text reads Disabled on this site.
  3. 2
    Click the cross icon on the top right corner to close this window and refresh the page.
  4. 3
    Click the cross icon on the top right corner to close this window and refresh the page.